Brain mitochondrial dysfunction in ovariectomized mice injected with d-galactose

Neurochemical Research

Volumn 35, Issue 3, 2010, Pages 399-404

  Su, Yang ^a   Sun, Hao ^a   Fang, Jie ^a   Hu, Gang ^a   Xiao, Ming ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; D galactose; Estrogen deprivation; Mitochondrial dysfunction; Oxidative stress

Indexed keywords

CYTOCHROME C OXIDASE; GALACTOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DEGENERATION; BRAIN MITOCHONDRION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; LIPID PEROXIDATION; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL TOXICITY; MOUSE; NEUROPATHOLOGY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; ATP SYNTHETASE COMPLEXES; BRAIN; BRAIN CHEMISTRY; ELECTRON TRANSPORT; FEMALE; GALACTOSE; HIPPOCAMPUS; MAZE LEARNING; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON; MITOCHONDRIA; OVARIECTOMY; OXIDATIVE STRESS;

MUS; RODENTIA;

EID: 76849089690     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0068-8     Document Type: Article

References (35)

1. WR Markesbery 1999 The role of oxidative stress in Alzheimer disease Arch Neurol 56 1449 1452 10.1001/archneur.56.12.1449 1:STN:280: DC%2BD3c%2FlvVyksw%3D%3D 10593298
2. G Perry A Nunomura K Hirai, et al. 2000 Oxidative damage in Alzheimer's disease: the metabolic dimension Int J Dev Neurosci 18 417 421 10.1016/S0736-5748(00)00006-X 1:CAS:528:DC%2BD3cXks1Sqs74%3D 10817925 (Pubitemid 30243071)
3. ZZ Chong F Li K Maiese 2005 Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease Prog Neurobiol 75 207 246 10.1016/j.pneurobio.2005.02.004 1:CAS:528:DC%2BD2MXktVOntbc%3D 15882775 (Pubitemid 40693131)
4. D Amantea R Russo G Bagetta, et al. 2005 From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens Pharmacol Res 52 119 132 10.1016/j.phrs.2005.03.002 1:CAS:528:DC%2BD2MXlsFCksr0%3D 15967377 (Pubitemid 40828362)
5. JW Simpkins JA Dykens 2008 Mitochondrial mechanisms of estrogen neuroprotection Brain Res Rev 57 421 430 10.1016/j.brainresrev.2007.04.007 1:CAS:528:DC%2BD1cXjs1Srtbc%3D 17512984
6. MX Tang D Jacobs Y Stern, et al. 1996 Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease Lancet 348 429 432 10.1016/S0140-6736(96)03356-9 1:CAS:528:DyaK28XlsValtrc%3D 8709781 (Pubitemid 26267873)
7. VW Henderson 2006 Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research Neuroscience 138 1031 1039 10.1016/j.neuroscience.2005.06. 017 1:CAS:528:DC%2BD28XitVGjsL4%3D 16310963 (Pubitemid 43306845)
8. XL Zhang B Jiang ZB Li, et al. 2007 Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose Pharmacol Biochem Behav 88 64 72 10.1016/j.pbb.2007.07.004 1:CAS:528:DC%2BD2sXhtVCmu7%2FP 17698178 (Pubitemid 47379823)
9. M Lei X Hua M Xiao, et al. 2008 Impairments of astrocytes are involved in the d-galactose-induced brain aging Biochem Biophys Res Commun 369 1082 1087 10.1016/j.bbrc.2008.02.151 1:CAS:528:DC%2BD1cXksVejtLc%3D 18329384
10. X Song M Bao D Li, et al. 1999 Advanced glycation in d-galactose induced mouse aging model Mech Aging Dev 108 239 251 10.1016/S0047-6374(99)00022-6 1:CAS:528:DyaK1MXjtFWqurk%3D 10405984 (Pubitemid 29240629)
11. SC Ho JH Liu RY Wu 2003 Establishment of the mimetic aging effect in mice caused by d-galactose Biogerontology 4 15 18 10.1023/A:1022417102206 1:CAS:528:DC%2BD3sXhtlahtrs%3D 12652185 (Pubitemid 36372272)
12. H Wei L Li Q Song, et al. 2005 Behavioural study of the d-galactose induced aging model in C57BL/6J mice Behav Brain Res 157 245 251 10.1016/j.bbr.2004.07.003 1:CAS:528:DC%2BD2MXisl2nsQ%3D%3D 15639175 (Pubitemid 40082567)
13. CF Chen SY Lang PP Zuo, et al. 2006 Effects of d-galactose on the expression of hippocampal peripheral-type benzodiazepine receptor and spatial memory performances in rats Psychoneuroendocrinology 31 805 811 10.1016/j.psyneuen.2006.03.004 1:CAS:528:DC%2BD28Xmt1Grt7s%3D 16707226 (Pubitemid 43928293)
14. X Cui P Zuo Q Zhang, et al. 2006 Chronic systemic d-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid J Neurosci Res 84 647 654 10.1002/jnr.20899 1:CAS:528:DC%2BD28XotlymsrY%3D 16710848 (Pubitemid 44196705)
15. DM Wu J Lu YL Zheng, et al. 2008 Purple sweet potato color repairs d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins Neurobiol Learn Mem 90 19 27 10.1016/j.nlm.2008.01.010 1:CAS:528:DC%2BD1cXmvVKlt7c%3D 18316211
16. M Lei Y Su X Hua, et al. 2008 Chronic systemic injection of d-galactose impairs the septohippocampal cholinergic system in rats Neuroreport 19 1611 1615 10.1097/WNR.0b013e3283136a1f 1:CAS:528:DC%2BD1cXht1ais7%2FP 18845941
17. HM Hsieh WM Wu ML Hu 2009 Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer's disease in C57BL/6J mice treated with d-galactose Food Chem Toxicol 47 625 632 10.1016/j.fct.2008.12.026 1:CAS:528:DC%2BD1MXhsFOmurw%3D 19146912
18. Y Luo F Niu Z Sun, et al. 2009 Altered expression of Abeta metabolism-associated molecules from d-galactose/AlCl(3) induced mouse brain Mech Ageing Dev 130 248 252 10.1016/j.mad.2008.12.005 1:CAS:528: DC%2BD1MXisFWhtbo%3D 19150622
19. X Hua M Lei Y Zhang, et al. 2007 Long-term d-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease Life Sci 80 1897 1905 10.1016/j.lfs.2007.02.030 1:CAS:528:DC%2BD2sXktF2rs7c%3D 17391708 (Pubitemid 46560732)
20. X Hua M Lei J Ding, et al. 2008 Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with d-galactose: a potential contribution to Alzheimer's disease processes Exp Neurol 210 709 718 10.1016/j.expneurol.2008.01.009 1:CAS:528:DC%2BD1cXksVKrsLc%3D 18289535
21. MF Beal 2005 Mitochondria take center stage in aging and neurodegeneration Ann Neurol 58 495 505 10.1002/ana.20624 1:CAS:528: DC%2BD2MXhtFGrs7fE 16178023 (Pubitemid 41377212)
22. K Leuner S Hauptmann R Abdel-Kader, et al. 2007 Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal 9 1659 1675 10.1089/ars.2007.1763 1:CAS:528:DC%2BD2sXhtVKqs7fN 17867931 (Pubitemid 47462969)
23. M Mancuso F Coppede L Murri, et al. 2007 Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? Antioxid Redox Signal 9 1631 1646 10.1089/ars.2007.1761 1:CAS:528:DC%2BD2sXhtVKqs7bE 17887917 (Pubitemid 47462967)
24. F Bosetti F Brizzi S Barogi, et al. 2002 Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease Neurobiol Aging 23 371 376.25 10.1016/S0197-4580(01)00314-1 1:CAS:528:DC%2BD38XivVShu7c%3D 11959398 (Pubitemid 34312019)
25. P Mitchell 1980 Proton motive cytochrome system of mitochondria Ann N Y Acad Sci 341 564 584 10.1111/j.1749-6632.1980.tb47199.x 1:CAS:528: DyaL3cXkvFShtLg%3D 6249160
26. XW Zhu AK Raina G Perry, et al. 2004 Alzheimer disease: the two-hit hypothesis Lancet Neurol 3 219 226 10.1016/S1474-4422(04)00707-0 1:CAS:528:DC%2BD2cXjvFyisbo%3D 15039034 (Pubitemid 38373660)
27. SK Tayebati 2006 Animal models of cognitive dysfunction Mech Ageing Dev 127 100 108 10.1016/j.mad.2005.09.026 16293295 (Pubitemid 43168304)
28. D Pratico K Uryu S Leight, et al. 2001 Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J Neurosci 21 4183 4187 1:CAS:528:DC%2BD3MXktlKls74%3D 11404403
29. K Schuessel S Schafer TA Bayer, et al. 2005 Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice Neurobiol Dis 18 89 99 10.1016/j.nbd.2004.09.003 1:CAS:528:DC%2BD2MXkslOhuw%3D%3D 15649699 (Pubitemid 40092899)
30. F Gu M Zhu J Shi, et al. 2008 Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice Neurosci Lett 440 44 48 10.1016/j.neulet.2008.05.050 1:CAS:528:DC%2BD1cXnt1Sksr0%3D 18539391
31. H Reichmann S Flörke G Hebenstreit, et al. 1993 Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease J Neurol 240 377 380 10.1007/BF00839971 1:STN:280: DyaK3szivFCrsg%3D%3D 8393094
32. EM Mutisya AC Bowling MF Beal 1994 Cortical cytochrome oxidase activity is reduced in Alzheimer's disease J Neurochem 63 2179 2184 1:CAS:528: DyaK2MXit12kurY%3D 7964738
33. R Dringen J Hirrlinger 2003 Glutathione pathways in the brain Biol Chem 384 505 516 10.1515/BC.2003.059 1:CAS:528:DC%2BD3sXjvVektb0%3D 12751781 (Pubitemid 36609167)
34. G Seifert K Schilling C Steinhauser 2006 Astrocyte dysfunction in neurological disorders: a molecular perspective Nat Rev Neurosci 7 194 206 10.1038/nrn1870 1:CAS:528:DC%2BD28Xhs1Gqt7g%3D 16495941 (Pubitemid 43292465)
35. H Liu H Wang S Shenvi, et al. 2004 Glutathione metabolism during aging and in Alzheimer disease Ann N Y Acad Sci 1019 346 349 10.1196/annals.1297.059 1:CAS:528:DC%2BD2cXms12nsrw%3D 15247041 (Pubitemid 38951332)